998. Antimicrobial stewardship program (ASP) advancement in Rhode Island (RI) since implementation of a statewide antimicrobial stewardship task force (RIASTF)
Session: Poster Abstract Session: Stewardship: Implementing Programs
Friday, October 4, 2013
Room: The Moscone Center: Poster Hall C
  • Version 3- IDWeek2013 Poster- RIASTF.pdf (214.6 kB)
  • Background: RI is one of only a few states with a statewide pharmacy ASP task force (RIASTF). Through collaboration between all acute care institutions in the state, its mission is to lead national efforts in reducing antimicrobial-resistant hospital-associated infections.

    Methods: Two 25-question self assessment surveys were developed in order to describe changes in ASP prevalence/characteristics in all acute care hospitals which may have been augmented by RIASTF’s establishment in May 2011.  A "Pre-Survey" assessed each hospital’s ASP involvement as of May 2011 and a "Post-Survey" assessed this as of February 2013. Hospital representatives who attended the RIASTF meetings completed the surveys on paper; for those not present, the survey was conducted by an investigator via telephone who then entered all answers into web-based versions of the survey.

    Results: Representatives from 100% (11/11) of RI's acute care hospitals responded to the surveys: 45.5% represented community hospitals and 54.5% represented teaching hospitals. Hospitals that reported having a full ASP program increased from 18.2% in 2011 to 54.5% in 2013; those without ASP plans decreased from 36.4% to 9.1%. The same top 2 barriers to ASPs were identified in 2011 and 2013 (lack of financial resources and lack of infectious disease personnel); however, their incidence decreased from 63.6% to 45.5% and 54.5% to 36.4%, respectively. Of hospitals that reported “not a priority” (27.2%) and “not consistent with institutional philosophy” (18.2%) as barriers in 2011, 0% reported these obstacles in 2013; those reporting “no barriers” increased from 0% to 36.4% from 2011 to 2013. Hospitals with no full time equivalents (FTEs) allotted to ASP pharmacists or physicians in 2011 decreased from 72.7% to 36.4% and 90.9% to 54.5%, respectively in 2013; those allotting >0.5 FTEs increased from 18.2% to 45.5% and 0% to 27.3%, respectively.

    Conclusion: Many studies describe the success of single hospital ASPs, but assessment of stewardship strategies across a larger statewide scale is limited.  Since the implementation of a statewide collaborative, there has been significant ASP advancement in RI; RIASTF may have played a role in this progress, thus supporting the adoption of similar programs in other states.

    Haley Morrill, PharmD1,2, Monica Dorobisz, PharmD3, Linda Nelson, PharmD4 and Kerry Laplante, PharmD1,2,5, (1)Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, (2)College of Pharmacy, University of Rhode Island, Kingston, RI, (3)Pharmacy, Kent Hospital, Warwick, RI, (4)Pharmacy, Women & Infants Hospital of Rhode Island, Providence, RI, (5)Warren Alpert School of Medicine, Brown University, Providence, RI


    H. Morrill, None

    M. Dorobisz, None

    L. Nelson, None

    K. Laplante, Pfizer Pharmaceuticals, Inc: Investigator, Educational grant
    Cubist Pharmaceuticals, Inc.: Consultant and Speaker's Bureau, Consulting fee
    Forrest Laboratories : Consultant, Consulting fee
    Astellas Pharma US, Inc: Consultant, Consulting fee

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.